Clinical Nutrition & Metabolism Department, Baltic Institute of Health Sciences, Latvia
Commentary
GLP-1 Agonists: Weight Loss, Multi-System Health Benefits
Author(s): Sofia A. Petrova*
Semaglutide, administered once-weekly, has demonstrated significant efficacy in
promoting substantial weight loss in adults who are overweight or obese. This research
positions semaglutide as a powerful therapeutic option extending beyond
its established role in type 2 diabetes management, marking a significant step
forward in pharmacological approaches to obesity... View More»
